Sanofi
The Sanofi Award aims to support innovative research in the field of severe obstructive respiratory diseases, where unmet medical needs remain significant. The two prizes are intended to recognise exceptional or promising projects that advance our understanding of and treatment for the following conditions: asthma, COPD or bronchiectasis.
By promoting excellence in research in Belgium, Sanofi aims to achieve scientific advances that will improve the quality of life for people suffering from obstructive lung diseases.
Basic Science Award: €5,000 €2,000 paid to him personally : €3,000 allocated to the continuation of the project :
Clinical Science Award: €7,000 €2,000 paid to him personally : €5,000 allocated to the continuation of the project :
Sanofi Basic Science Award 2025
Vincent Geudens
Unravelling the structural and cellular mechanisms underlying mucus plugs and small airway damage in COPD using spatial imaging and multi-omic approaches.
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death worldwide and is characterised by considerable heterogeneity.
Mucus plugs and damage to the small airways are increasingly recognised as major factors in respiratory obstruction…
Sanofi Clinical Science Award 2025
Pauline Vermoesen
AIRBREES – A study into the impact of environmental respiratory exposures on bronchiectasis
The management of bronchiectasis is moving towards a personalised approach based on the identification of ‘treatable traits’. However, the role of environmental factors and lifestyle remains poorly understood. We have therefore launched an exploratory study in two Flemish hospitals. Patients complete an exposure questionnaire based on the European EXIMIOUS and ECRHS projects. These data are combined with…